Jean-Sébastien Hoffmann

Title: Innovations by Jean-Sébastien Hoffmann

Introduction

Jean-Sébastien Hoffmann is a notable inventor based in Toulouse, France. He has made significant contributions to the field of cancer diagnostics, particularly in understanding lung cancer aggressiveness and genetic instability. With a total of 2 patents, Hoffmann's work is paving the way for advancements in personalized medicine.

Latest Patents

Hoffmann's latest patents include innovative methods for diagnosing lung cancer aggressiveness. The first patent describes a method that involves detecting an expression profile of specific genes, including CDC6, CLASPIN, PLK1, and POLQ, from a lung cancer sample. This method allows for the comparison of the expression profile to a reference, ultimately aiding in the diagnosis of cancer aggressiveness. Additionally, he has developed a method for diagnosing cancer aggressiveness and genetic instability by measuring the expression level of the POLQ gene in a cancer sample. This method calculates a ratio of POLQ expression to a control gene, providing critical insights into the patient's condition.

Career Highlights

Hoffmann has worked with esteemed institutions such as the National Centre for Scientific Research (Centre National De La Recherche Scientifique) and the University Paul Sabatier Toulouse III. His research has focused on developing diagnostic tools that can significantly impact cancer treatment strategies.

Collaborations

Throughout his career, Hoffmann has collaborated with notable colleagues, including Christophe Cazaux and Jean-Christophe Bourdon. These partnerships have contributed to the advancement of his research and the development of innovative diagnostic methods.

Conclusion

Jean-Sébastien Hoffmann's contributions to cancer diagnostics exemplify the importance of innovation in medical research. His patents reflect a commitment to improving patient outcomes through advanced diagnostic techniques.